Skip to search.
 TSX Up 0.06% TSX Ventures Up 0.46%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
24.30 Down 0.18(0.74%) Aug 26, 4:00PM EDT
|After Hours : 24.30 Up 0.00 (0.02%) Aug 26, 5:02PM EDT
Prev Close:24.48
Open:24.63
Bid:23.88 x 100
Ask:25.29 x 100
1y Target Est:39.71
Beta:1.02753
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:24.05 - 25.01
52wk Range:23.59 - 43.63
Volume:414,174
Avg Vol (3m):527,711
Market Cap:1.12B
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ACORDown 0.74%1.12B
BIIBUp 0.43%67.53B

Key Statistics

Forward P/E (1 yr):32.40
P/S (ttm):2.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.44
Quarterly EPS Est (Sep-16) :0.12
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):1.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback